The 2026 Pharmaceutical and Bio Investment Expo will be held on November 19 at Songdo Convensia in Incheon.


The event was organized to support domestic pharmaceutical and biotech companies in attracting investment and developing overseas sales channels. Around 300 people, including domestic and international investment institutions, buyers, and industry representatives, are expected to attend.


The event will feature an expert conference addressing key industry issues, including AI-based innovation in the bio industry, open innovation, global research and development (R&D) trends, and mergers and acquisitions (M&A).


Speakers will include experts from leading companies such as SK bioscience, LOTTE BIOLOGICS, and Celltrion, as well as investment and analysis institutions such as Shinhan Securities and Samil PwC. They will share insights on contract development and manufacturing organization (CDMO) strategies, initial public offerings (IPOs), and venture capital (VC) investment opportunities.


In addition, one-on-one investment and export consultations will be held with 20 domestic and international investors and buyers and 50 domestic pharmaceutical and biotech companies. International participants are also scheduled to visit major facilities in the Songdo Bio Cluster.



An Incheon City official said, "We hope this event will serve as an opportunity for domestic pharmaceutical and biotech companies to meet directly with global investors and explore new business opportunities."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing